C07J7/008 - CPC Classification Index

ClassID:

96509 ⎘

C07J7/008 - CPC Classification

Classification description:

Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21

Sub-classes:

C07J7/0085 » {by an halogen atom} 47
C07J7/009 » {by only one oxygen atom doubly bound} 46
C07J7/0095 » {carbon in position 21 is part of carboxylic group} 0

Recent Application in this class:

20260000681

2026-01-01

ENZYMATIC PROCESS FOR OBTAINING 17 ALPHA-MONOESTERS OF CORTEXOLONE AND/OR ITS 9,11-DEHYDRODERIVATIVES

20250387412

2025-12-25

ENZYMATIC PROCESS FOR OBTAINING 17 ALPHA-MONOESTERS OF CORTEXOLONE AND/OR ITS 9,11-DEHYDRODERIVATIVES

20250074935

2025-03-06

HETERODIMER COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS

20240368213

2024-11-07

COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS

20230287037

2023-09-14

3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF

20230113666

2023-04-13

Compositions and methods for treating CNS disorders

20230104965

2023-04-06

ENZYMATIC PROCESS FOR OBTAINING 17 ALPHA-MONOESTERS OF CORTEXOLONE AND/OR ITS 9,11-DEHYDRODERIVATIVES

20220280531

2022-09-08

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

20220220150

2022-07-14

Compositions and methods for treating CNS disorders

#10

20220106351

2022-04-07

HETERODIMER COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS

#11

20210347809

2021-11-11

Heterodimer compositions and methods for the treatment of ocular disorders

#12

20210040141

2021-02-11

3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF

#13

20200392177

2020-12-17

Compositions and methods for treating CNS disorders

#14

20200223884

2020-07-16

3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF

#15

20200155572

2020-05-21

Enzymatic process for obtaining 17 α-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#16

20200016178

2020-01-16

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

#17

20190365786

2019-12-05

PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 4-PREGENEN-11BETA-17-21-TRIOL-3,20-DIONE DERIVATIVES

#18

20190127413

2019-05-02

Compositions and Methods for Non-Toxic Delivery of Antiprogestins

#19

20190083511

2019-03-21

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#20

20180147217

2018-05-31

Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives

#21

20180141971

2018-05-24

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

#22

20170342103

2017-11-30

3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof

#23

20170240589

2017-08-24

Compositions and methods for treating CNS disorders

#24

20170182062

2017-06-29

4-pregenen-11β-17-21-triol-3,20-dione derivatives

#25

20170114088

2017-04-27

Process for the preparation of 17-desoxy-corticosteroids

#26

20170057990

2017-03-02

Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size

#27

20170022245

2017-01-26

GANAXOLONE DERIVATIVES FOR TREATMENT OF CENTRAL NERVOUS SYSTEMS DISORDERS

#28

20160326210

2016-11-10

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#29

20160324873

2016-11-10

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#30

20160083417

2016-03-24

19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof

#31

20160060289

2016-03-03

Non-hormonal steroid modulators of NF-κB for treatment of disease

#32

20160051566

2016-02-25

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#33

20150291654

2015-10-15

3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF

#34

20150203526

2015-07-23

NOVEL 19-NOR-STEROIDS AND THEIR USE FOR TREATING PROGESTERONE- DEPENDENT CONDITIONS

#35

20150166597

2015-06-18

Polymorphic forms of a steroid-like compound and methods for the preparation and use thereof

#36

20150057258

2015-02-26

4-pregenen-11β-17-21-triol-3,20-dione derivatives

#37

20150005519

2015-01-01

Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives

#38

20140179654

2014-06-26

Enzymatic process for obtaining 17α-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#39

20140135298

2014-05-15

Mutation mimicking compounds that bind to the kinase domain of EGFR

#40

20140050791

2014-02-20

Optimized synthesis of pure, non-polymorphic, crystalline bile acids with defined particle size

#41

20130274234

2013-10-17

NOVEL 19-NOR-STEROIDS AND THEIR USE FOR TREATING PROGESTERONE- DEPENDENT CONDITIONS

#42

20130211069

2013-08-15

PROCESS FOR THE PREPARATION OF 17-DESOXY-CORTICOSTEROIDS

#43

20130196962

2013-08-01

Non-hormonal steroid modulators of NF-κB for treatment of disease

#44

20130123226

2013-05-16

Pharmaceutical compositions and methods of use 4-pregenen-11β-17-21-triol-3,20-dione derivatives

#45

20130123223

2013-05-16

4-pregenen-11β-17-21-triol-3,20-dione derivatives

#46

20130018027

2013-01-17

COMPOSITIONS AND METHODS FOR NON-TOXIC DELIVERY OF ANTIPROGESTINS

#47

20110092472

2011-04-21

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

#48

20090227548

2009-09-10

Glucocorticoid receptor agonists